跳至主要内容
临床试验/NCT01571843
NCT01571843已完成不适用

Effect of Mechanical Loading on Radius Bone Density and Microarchitecture in Primary Hyperparathyroidism

Columbia University1 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2010年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
12
试验地点
1
主要终点
Proportion of subjects with improved bone mass and bone quality at the 1/3 radius

研究概览

简要总结

The purpose of the study is to determine the effect of forearm exercise on forearm bone density in post-menopausal women with or without primary hyperparathyroidism.

The investigators hypothesize that forearm exercise will increase forearm bone density in patients with primary hyperparathyroidism more so than in patients without primary hyperparathyroidism.

详细描述

Primary hyperparathyroidism (PHPT), a disease characterized by excess parathyroid hormone (PTH) and high blood calcium, is one of the most common endocrine disorders.

PHPT is seen most often in post-menopausal women. Kidney stones and bone deformities were prominent manifestations of the disease in the past, however, PHPT is now primarily asymptomatic due to incidental detection of high blood calcium levels.

Many patients with PHPT, however, have low bone mineral density (BMD) when bone mass is measured by dual energy x-ray absorptiometry (DXA), primarily at the forearm.

There is no effective medical therapy which increases bone density at the forearm in patients with PHPT. PTH both builds and breaks down bone, and the pathways by which PTH mediates these actions are beginning to be identified. Prior research suggests that mechanical loading shifts PTH towards building bone. Arm exercise is an attractive option for the treatment of low forearm BMD in patients with PHPT since it is often the site most affected by excess PTH.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
45 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者
是

入选标准

  • •Inclusion criteria for primary hyperparathyroidism group:
  • •Primary hyperparathyroidism (defined by an elevated serum calcium and concomitantly elevated or inappropriately normal PTH)
  • •Female sex, postmenopausal status for at least five years, ages 45-80
  • •English- or Spanish-speaking
  • •DXA T-score less than -1.0 at the one-third radius
  • •Physically capable of exercise
  • •25-hydroxyvitamin D >20 ng/mL. The latter inclusion criterion will lead to the enrollment of some individuals whose vitamin D stores will not be frankly low. We feel, however, that it is better to study subjects in their usual state rather than replacing them with vitamin D which could add another variable that would further complicate this pilot study.
  • •Inclusion criteria for the osteopenic control:
  • •Female sex, postmenopausal status for at least five years ages 45-80
  • •English- or Spanish-speaking
  • •DXA T-score less than -1.0 at the one-third radius
  • •Physically capable of exercise
  • •Normal serum calcium and PTH level
  • •25-hydroxyvitamin D >20 ng/mL

排除标准

  • •Men, premenopausal women, women less than age 45 or greater than age 80
  • •Familial hypocalciuric hypercalcemia
  • •Current or prior use of bisphosphonates (alendronate or risedronate (within 12 months), ibandronate (within 6 months), other bisphosphonate (2 years)
  • •Current use of cinacalcet
  • •Current or prior use of estrogen replacement therapy (within 2 years)
  • •Planned parathyroidectomy (within one year)
  • •Planned initiation of bisphosphonates
  • •DXA T-score greater than -1.0 at the one-third radius
  • •Cardiovascular disease or uncontrolled hypertension
  • •Exercise-limiting pulmonary diseases
  • •Malignancy other than non-melanomatous skin cancer or microscopic thyroid cancer (within 5 years)
  • •Renal failure
  • •Secondary hyperparathyroidism
  • •Celiac disease
  • •Physical/orthopedic disabilities and neurologic disorders or vasculopathies that would place the subjects at risk or limit their ability to perform exercise (eg. arthritis, carpal tunnel syndrome, rotator cuff injury, etc)
  • •Moderate or high physical activity (category 2 or 3) as assessed by the IPAQ questionnaire. This latter exclusion criterion is a measure of baseline physical activity and looks to exclude those who would have a lower likelihood of benefit by baseline participation in an exercise program.
  • •Protected individuals (institutionalized), prisoners, and any other prospective participant who might not be able to give voluntary informed consent.

研究组 & 干预措施

PHPT/ Walking + Forearm exercise

Experimental

Ten participants with PHPT will be randomized to the intervention of 52 weeks of the forearm exercise program plus walking.

干预措施: Forearm exercise program (Other)

PHPT/ Walking alone

Placebo Comparator

Ten participants with PHPT will be randomized to the intervention of 52 weeks of the walking program alone. Walking will consist of 30 minutes at a moderate pace every other day for 52 weeks.

干预措施: Walking program (Other)

Osteopenia/ Walking + Forearm exercise

Active Comparator

Ten healthy, postmenopausal women with osteopenia will be randomized to the intervention of 52 weeks of the forearm exercise program plus walking.

干预措施: Forearm exercise program (Other)

Osteopenia/ Walking alone

Placebo Comparator

Ten healthy, postmenopausal women with osteopenia will be randomized to the intervention of 52 weeks of the walking program alone. Walking will consist of 30 minutes at a moderate pace every other day for 52 weeks.

干预措施: Walking program (Other)

结局指标

主要结局

Proportion of subjects with improved bone mass and bone quality at the 1/3 radius

时间窗: 1 year

The primary outcome is proportion of subjects with improved bone mass and bone quality at the 1/3 radius over one year.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

John P. Bilezikian

Dorothy L. and Daniel H. Silberberg Professor of Medicine and Pharmacology

Columbia University

研究点 (1)

Loading locations...

相似试验